Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $2.71 Million - $3.24 Million
-44,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $2.36 Million - $2.75 Million
44,000 New
44,000 $2.74 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $669,300 - $740,100
-15,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $676,800 - $807,000
15,000 New
15,000 $716,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Polar Asset Management Partners Inc. Portfolio

Follow Polar Asset Management Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Polar Asset Management Partners Inc. with notifications on news.